Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Institutional Investor > Frazier Life Sciences Management, L.p. > Profile

Instuitional Investor - Frazier Life Sciences Management, L.p.

Fund Profile
Filing Period:
Fund Name: Frazier Life Sciences Management, L.p.
Portfolio Value $2,500,738,743
Top 13F Holdings
Filing Period:
No. Security Ticker Shares Value % Port
1.
Mirum Pharmaceuticals Inc.
 MIRM 6,795,121 $345,803,708 13.83%
2.
Verona Pharma Plc
 VRNA 3,383,950 $320,053,991 12.8%
3.
Newamsterdam Pharma Company
 16,607,074 $300,754,110 12.03%
4.
Bridgebio Pharma Inc.
 BBIO 3,800,457 $164,103,733 6.56%
5.
Arcutis Biotherapeutics Inc.
 ARQT 9,874,511 $138,440,644 5.54%
Insider Monkey Quarterly Strategy
+373.4% Insider Monkey Quarterly Strategy
+154.9% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through February 19th, 2025)